CLOs on the Move


 
TexPower is a startup company spun out of the University of Texas at Austin in early 2019. They aim to commercialize the world’s first cobalt free, high energy, drop in cathode materials for lithium ion battery (LIB) manufacturers across the U.S. and b...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Iosco County Road Commission

Iosco County Road Commission is a Tawas City, MI-based company in the Computers & Electronics sector.

Nuvation Research Corp

Nuvation Research Corp is one of the leading companies in the Computers & Electronics sector.

Sentry Safety Supply

Sentry Safety Supply is a Peoria, IL-based company in the Computers & Electronics sector.

Gelest

Gelest, Inc., headquartered in Morrisville, PA, USA, was founded in 1991 to serve the advanced technology applications markets and is recognized worldwide as an innovator, manufacturer and supplier of Organo-Silicon and Metal-Organic materials for commercial production and R&D support. Since its inception, Gelest, Inc. has continuously added experts in the fields of silanes, silicones, and metal-organics. The technical staff includes individuals with extensive hands-on experience and academic credentials (see Management Team). Joint developments between customers and staff have led to an increased product offering from several hundred materials to the current listing of several thousand materials. The company has focused its research and development efforts toward expanding the offering of Group 4A and 4B analogs. Gelest, Inc. offers the most comprehensive selection of silane, silicone, and metal-organic materials in the world.

Xceleron

Xceleron believes that AMS technology and our expertise can get life-changing products (drugs and biobased) quickly and cost-effectively to people who need them.  We work with integrity and an open mind and are driven by science and the spirit of collaboration. Founded in 1997 in York, UK, and now headquartered in Germantown, Maryland, Xceleron pioneered human microdose and microtracer techniques using AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I, and Phase II/III clinical trials. Xceleron’s experience is especially valuable because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.